- Home
- Editorial
- News
- Practice Guidelines
- Anesthesiology Guidelines
- Cancer Guidelines
- Cardiac Sciences Guidelines
- Critical Care Guidelines
- Dentistry Guidelines
- Dermatology Guidelines
- Diabetes and Endo Guidelines
- Diagnostics Guidelines
- ENT Guidelines
- Featured Practice Guidelines
- Gastroenterology Guidelines
- Geriatrics Guidelines
- Medicine Guidelines
- Nephrology Guidelines
- Neurosciences Guidelines
- Obs and Gynae Guidelines
- Ophthalmology Guidelines
- Orthopaedics Guidelines
- Paediatrics Guidelines
- Psychiatry Guidelines
- Pulmonology Guidelines
- Radiology Guidelines
- Surgery Guidelines
- Urology Guidelines
Omega-3 linked to reduction in Depression
London : Omega-3 fatty acids play a critical role in the development and function of the central nervous system, say British scientists who found a link between Omega-3 supplementation and reduction in depression.
A new meta analysis by British researchers supports the link between intake of EPA and DHA omega-3 fatty acids the kind found in fish and reduction in major depressive disorder (MDD).
The meta-analysis includes 13 studies with 1,233 participants.
The findings showed a benefit for EPA and DHA comparable to effects reported in meta-analyses of anti-depressants.
The effect was greater in studies supplementing higher doses of EPA and performed in patients already on anti-depressants.
The paper was published in the journal Translational Psychiatry.
"This new meta-analysis nuances earlier research on the importance of long chain omega-3s in MDD," said lead study author R.J.T. Mocking from the University of Amsterdam, the Netherlands.
Source : IANS
A new meta analysis by British researchers supports the link between intake of EPA and DHA omega-3 fatty acids the kind found in fish and reduction in major depressive disorder (MDD).
The meta-analysis includes 13 studies with 1,233 participants.
The findings showed a benefit for EPA and DHA comparable to effects reported in meta-analyses of anti-depressants.
The effect was greater in studies supplementing higher doses of EPA and performed in patients already on anti-depressants.
The paper was published in the journal Translational Psychiatry.
"This new meta-analysis nuances earlier research on the importance of long chain omega-3s in MDD," said lead study author R.J.T. Mocking from the University of Amsterdam, the Netherlands.
Source : IANS
Next Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd